RAPT Therapeutics Stock (NASDAQ: RAPT) stock price, news, charts, stock research, profile.
Open | $8.860 |
Close | $8.980 |
Volume / Avg. | 860.933K / 1.232M |
Day Range | 8.710 - 9.000 |
52 Wk Range | 6.860 - 27.350 |
Market Cap | $309.700M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 37 |
Short Interest | 13.62% |
Days to Cover | 9.29 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of RAPT Therapeutics (NASDAQ: RAPT) through any online brokerage.
Other companies in RAPT Therapeutics’s space includes: Humacyte (NASDAQ:HUMA), Adverum Biotechnologies (NASDAQ:ADVM), Precigen (NASDAQ:PGEN), Gritstone Bio (NASDAQ:GRTS) and Inovio Pharmaceuticals (NASDAQ:INO).
The latest price target for RAPT Therapeutics (NASDAQ: RAPT) was reported by JP Morgan on Wednesday, March 27, 2024. The analyst firm set a price target for 13.00 expecting RAPT to rise to within 12 months (a possible 46.07% upside). 20 analyst firms have reported ratings in the last year.
The stock price for RAPT Therapeutics (NASDAQ: RAPT) is $8.9 last updated March 28, 2024 at 5:24 PM EDT.
There are no upcoming dividends for RAPT Therapeutics.
RAPT Therapeutics’s Q4 earnings are confirmed for Thursday, March 9, 2023.
There is no upcoming split for RAPT Therapeutics.
RAPT Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.